education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Zerlin
Zerlin
sertraline
Manufacturer:
Pharos
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Sertraline
Indications/Uses
All types of depression w/ or w/o a history of mania. Prevention of relapse of initial or recurrent episodes of depression.
Dosage/Direction for Use
1 tab daily. Max: 200 mg daily.
Administration
May be taken with or without food.
Contraindications
Concomitant or w/in 2 wk of MAOI therapy.
Adverse Reactions
Dry mouth, nausea, diarrhea/loose stool, male sexual dysfunction (primary ejaculatory delay), increased sweating, dyspepsia.
View
ADR Monitoring Form
Drug Interactions
MAOIs. Lithium, tryptophan, highly protein-bound drugs.
MIMS Class
Antidepressants
ATC Classification
N06AB06 - sertraline ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.
Regulatory Classification
G
Presentation/Packing
Form
Zerlin film-coated tab 50 mg
Packing/Price
3 × 10's (Rp356,400/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in